A pill to treat postpartum depression is approved by the FDA
The U.S. Food and Drug administration said Zurzuvae treats postpartum depression. What is postpartum depression? Is there a cure for postpartum depression?
Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug administration said Zurzuvae treats postpartum depression. What is postpartum depression? Is there a cure for postpartum depression?
The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
The FDA approval of zuranolone marks “a very important step forward” for the field of maternal mental health, Dr. Samantha Meltzer-Brody, director of the Center for Women’s Mood Disorders at the University of North Carolina at Chapel Hill, said in an email. She was one of the investigators on the zuranolone clinical trials.
The US Food and Drug Administration has approved the medication zuranolone for the treatment of major depressive disorder and severe postpartum depression – making it the first FDA-approved oral pill in the United States specifically for postpartum depression, a serious mental illness that can develop in about 1 in 7 new mothers after childbirth.
(CNN) — The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression – making it the first FDA-approved oral pill in<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-approves-first-postpartum-depression-pill-in-the-us/">Read More</a>